Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Original Article

Comparison of dialysis and death in renal transplant patients treated with SGLT2 or DPP-4 inhibitors

The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Citation & Authors

Am J Transplant. 2025;25(9):1954-1964.

Fu-Shun Yen; Chih-Cheng Hsu; Yun-Kai Yeh; Wan-Yin Cheng; Pei-Lun Liao; Chii-Min Hwu; James Cheng-Chung Wei

ABSTRACT · RESEARCH SUMMARY

Research summary

The TriNetX study matched 1,410 pairs of new users with kidney transplantation and diabetes. Compared with DPP-4 inhibitors, SGLT2 inhibitors were associated with lower risks of dialysis (HR 0.694) and all-cause mortality (0.687). Post-transplant infection, rejection, and hospitalization did not differ significantly. These findings suggest possible kidney and survival benefits, but stronger causal evidence is needed.

Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗